Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Life Expectancy of Hiv-Positive Patients After Diagnosis in Iran From 1986 to 2016: A Retrospective Cohort Study at National and Sub-National Levels Publisher Pubmed



Mirzaei M1 ; Farhadian M2 ; Poorolajal J3 ; Kazerooni PA4 ; Tayeri K5 ; Mohammadi Y6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  2. 2. Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  3. 3. Modeling of Noncommunicable Diseases Research Center, Department of Biostatistics and Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  4. 4. HIV/AIDS Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Iranian Research Center of HIV and AIDS, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Social Determinants of Health Research Center, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran

Source: Epidemiology and Health Published:2018


Abstract

OBJECTIVES: Little is known about the life expectancy of individuals with human immunodeficiency virus (HIV) in Iran. This study therefore aimed to estimate the life expectancy of HIV-positive patients in Iran. METHODS: In this retrospective cohort study, we extracted data from the Center for Disease Control and Prevention of the Ministry of Health and Medical Education and the Death Registration System. We included patients aged 20 years and older who had a specified date of diagnosis. We estimated life expectancy and its 95% confidence intervals (CIs) using Chiang's methodology. RESULTS: The overall life expectancy at the national level was 23.1 years (95% CI, 22.6 to 23.5). Life expectancy was 21.6 years (95% CI, 21.1 to 22.0) for men and 32.7 years (95% CI, 31.4 to 34.0) for women. The life expectancy of patients who did or did not receive antiretroviral therapy (ART) was 37.0 years (95% CI, 36.2 to 37.8) and 15.5 years (95% CI, 15.1 to 15.9), respectively. The life expectancy of patients with or without tuberculosis (TB) was 21.6 years (95% CI, 20.4 to 22.9) and 36.5 years (95% CI, 35.7 to 37.4), respectively. CONCLUSIONS: The life expectancy of Iranian HIV-positive patients was found to be very low. To improve their longevity, improvements in ART coverage and the control and treatment of TB are advised. © 2018, Korean Society of Epidemiology.
Related Docs
1. Survival Rate and the Determinants of Progression From Hiv to Aids and From Aids to the Death in Iran: 1987 to 2016, Asian Pacific Journal of Tropical Medicine (2019)
2. Investegation of Factors Associated With Tcd4 + Lymphocyte Count Change and Survival of Hiv+ Patients Using Joint Model With Longitudinal and Survival Measurements, Scientific Journal of Kurdistan University of Medical Sciences (2021)
3. The Trend of Interpersonal Violence Mortality at National and Provincial Levels in Iran From 1990 to 2015, Journal of Interpersonal Violence (2021)
4. Ranking Universities of Medical Sciences As Public Health Services Provider Institutions in Iran: A Result-Chain Analysis, Archives of Iranian Medicine (2022)
5. Trend of Appendicitis Mortality at National and Provincial Levels in Iran From 1990 to 2015, Archives of Iranian Medicine (2020)
6. The Trend of Fall-Related Mortality at National and Provincial Levels in Iran From 1990 to 2015, International Journal of Injury Control and Safety Promotion (2020)
7. Predictors of Tuberculosis in Hiv/Aids Patients Referred to Behavioral Diseases Consultation Center: A Registry-Based Study in Abadan, Southwest of Iran, Shiraz E Medical Journal (2016)
Experts (# of related papers)
View all Related Experts
Payman Salamati (3)
Vafa Rahimi-Movaghar (3)